These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32629170)

  • 21. Polymer-drug conjugates as modulators of cellular apoptosis.
    Vicent MJ
    AAPS J; 2007 Jun; 9(2):E200-7. PubMed ID: 17907762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
    Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM
    Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric micelles for drug delivery.
    Aliabadi HM; Lavasanifar A
    Expert Opin Drug Deliv; 2006 Jan; 3(1):139-62. PubMed ID: 16370946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
    Gaspar R; Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1220-31. PubMed ID: 19682513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymer-drug and polymer-protein conjugated nanocarriers: Design, drug delivery, imaging, therapy, and clinical applications.
    Guo H; Mi P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1988. PubMed ID: 39109479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in polymer drug conjugates.
    Sharma R; Singla N; Mehta S; Gaba T; Rawal RK; Rao HS; Bhardwaj TR
    Mini Rev Med Chem; 2015; 15(9):751-61. PubMed ID: 25985952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reductively cleavable polymer-drug conjugates based on dendritic polyglycerol sulfate and monomethyl auristatin E as anticancer drugs.
    Rades N; Achazi K; Qiu M; Deng C; Haag R; Zhong Z; Licha K
    J Control Release; 2019 Apr; 300():13-21. PubMed ID: 30794827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of polymeric nanostructure shape on drug delivery.
    Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable amphiphilic polymer-drug conjugate micelles.
    Hu X; Jing X
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1079-90. PubMed ID: 19645633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.
    Duncan R; Ringsdorf H; Satchi-Fainaro R
    J Drug Target; 2006 Jul; 14(6):337-41. PubMed ID: 17092834
    [No Abstract]   [Full Text] [Related]  

  • 31. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological effects of soluble synthetic polymers as drug carriers.
    Duncan R
    Crit Rev Ther Drug Carrier Syst; 1985; 1(4):281-310. PubMed ID: 3913527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers.
    Loyer P; Cammas-Marion S
    J Drug Target; 2014 Aug; 22(7):556-75. PubMed ID: 25012064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymer-drug conjugates: current status and future trends.
    Greco F; Vicent MJ
    Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thinking Outside the 'Block': Alternative Polymer Compositions for Micellar Drug Delivery.
    Jones MC
    Curr Top Med Chem; 2015; 15(22):2254-66. PubMed ID: 26043738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymer--drug conjugates as nano-sized medicines.
    Canal F; Sanchis J; Vicent MJ
    Curr Opin Biotechnol; 2011 Dec; 22(6):894-900. PubMed ID: 21724381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted polymer-drug conjugates: Current progress and future perspective.
    Xu H; Ma H; Yang P; Zhang X; Wu X; Yin W; Wang H; Xu D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():729-34. PubMed ID: 26513756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting EPR in polymer drug conjugate delivery for tumor targeting.
    Modi S; Prakash Jain J; Domb AJ; Kumar N
    Curr Pharm Des; 2006; 12(36):4785-96. PubMed ID: 17168778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of polymeric refabrication techniques to modify polymer properties for biomedical and drug delivery applications.
    Pillay V; Seedat A; Choonara YE; du Toit LC; Kumar P; Ndesendo VM
    AAPS PharmSciTech; 2013 Jun; 14(2):692-711. PubMed ID: 23543606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.